Oxycodone and Acetaminophen CII Tablets USP, 7.5 mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0522-01. Case label: SpecGx LLC, NDC 0406052201, Exp. 2027/03, Lot: 0522J23493
Published January 14, 2026 · Recall initiated: December 16, 2025
Summary
FDA records drug Class II recall D-0255-2026, published January 14, 2026 and initiated December 16, 2025. Recalling firm: SpecGx, LLC; Status: Ongoing; Reported quantity: 74,544 bottles; Lot: Lot: 0522J23493, expires: 03/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.
What to do
Voluntary: Firm initiated · E-Mail
Get an email if OXYCODONE AND ACETAMINOPHEN has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- OXYCODONE AND ACETAMINOPHEN
- Manufacturer
- SpecGx, LLC
- Distributor
- Nationwide
- UPC
- 0304060522053
- Lot
- Lot: 0522J23493, expires: 03/2027.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAOxycodone and Acetaminophen CII Tablets USP, 10mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MOJanuary 14, 2026
- FDAReBoost Nasal Spray, 0.68 fl. oz. (20 mL) bottles, Distributed by: MediNatura, 10421 Research Rd., SE,January 14, 2026
- FDAORL Kids Natural Toothpaste, Bubblegum Flavor, 4 oz (120ml), ORL Labs, LLC, Scottsdale, Arizona USAJanuary 14, 2026
- FDAClearLife Allergy Nasal Spray, Extra Strength, 0.68 fl. oz. (20 mL) bottles, Distributed by: MediNatura, 10421January 14, 2026
- FDAORL Kids Mouthwash, Bubblegum Flavor, 16.9 oz. (500ml) per bottle, ORL Labs, LLC, Scottsdale, Arizona USAJanuary 14, 2026
- FDAOxycodone and Acetaminophen Tablets, USP 10 mg*/325 mg 100-count bottles, Rx Only, Distributed by: AurobindoApril 22, 2020
Questions about this recall
Was Oxycodone and Acetaminophen CII Tablets USP, 7.5 mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0522-01. Case label: SpecGx LLC, NDC 0406052201, Exp. 2027/03, Lot: 0522J23493 recalled?
Yes. FDA published recall D-0255-2026 on January 14, 2026. Reported hazard: Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: OXYCODONE AND ACETAMINOPHEN. UPC: 0304060522053.